Apply Now

News » Archives » November 2015

Physicist Jay LaVerne named AAAS fellow

Author: William G. Gilroy

 

jaylaverne

Jay LaVerne, professional specialist in the University of Notre Dame’s Radiation Laboratory and a concurrent research professor of physics, has been named a fellow of the American Association for the Advancement of Science (AAAS) in honor of his efforts toward advancing science applications that are deemed scientifically or socially distinguished.

LaVerne’s research concerns the examination of the energy loss, charge and other properties of ionizing radiation and to elucidate the fundamental radiolytic decomposition of molecules and the subsequent kinetics of the reactive transients. Read More

Notre Dame’s Emily Mediate named Rhodes Scholar

Author: Sue Lister

Emily Mediate

Emily Mediate, a 2015 University of Notre Dame graduate, has been selected to the American Rhodes Scholar Class of 2016. A native of Colorado Springs, Colorado, Mediate was one of 32 Rhodes Scholars selected from a pool of 869 candidates who had been endorsed by their colleges and universities. She is Notre Dame’s 17th Rhodes Scholar, and will commence her studies at Oxford University in October 2016. Read More

Research Like a Champion Today

Author: Jenna Bilinski

The University of Notre Dame is full of brilliant students with innovative ideas that one day could change the world. Unfortunately, some ideas never get beyond the planning stage due to lack of funding.

That’s where a unique opportunity comes in. 

Research Like a Champion Read More

The Changing Image of Cancer Research:  Cancer Engineering Wins at CABTRAC

Author: Jenna Bilinski

The Changing Image of Cancer Research:  Cancer Engineering Wins at CABTRAC

October 2015

prakash_1

As a collaboration between 50 academic institutions nationwide and the National Cancer Institute’s (NCI) Training Branch, the Cancer Biology Training Consortium (CABTRAC) brings together leaders in cancer research dedicated to training the next generation of cancer researchers, in part through NCI-sponsored training grants... Read more Read More

NDIGD, PAD Project win USAID Development Innovation Ventures award

Author: Meg McDermott

This paper test card is inexpensive way to distinguish substitutes or diluted drugs from real medicines used to treat common bacterial infections and tuberculosis

The Notre Dame Initiative for Global Development and Marya Lieberman have won a USAID Development Innovation Ventures award to improve global health. Lieberman, associate professor of chemistry and biochemistry at the University of Notre Dame, will expand her Paper Analytical Device research in Kenya.

Many pharmaceuticals, particularly those purchased in the developing world, are of poor quality or fake. The Paper Analytical Device project, supported by the College of Science and the Eck Institute for Global Health, allows users to quickly determine whether a drug tablet contains the correct medicines. Read More

Warren Family Research Center for Drug Discovery and Development partners with Retrophin and the Grace Wilsey Foundation

Author: Marissa Gebhard

The Warren Family Research Center for Drug Discovery and Development at the University of Notre Dame has established a research collaboration with Retrophin, Inc. and the Grace Wilsey Foundation to focus on developing treatment for NGLY1 deficiency.    

Notre Dame Drug Discovery

The partnership aims to develop a novel therapeutic for patients with NGLY1 deficiency, a rare genetic disorder. NGLY1 deficiency is believed to be caused by a deficiency in an enzyme called N-glycanase-1. The condition is characterized by a variety of symptoms, including global developmental delay, movement disorder, seizures, and ocular abnormalities.

Under this collaboration, the Grace Wilsey Foundation will provide support and funding to Retrophin to enable collaborative discovery efforts, with researchers in the Warren Center, that aim to validate and address a new molecular target that may be relevant to NGLY1 deficiency. Read More